Metsera

Metsera Operating Cash Flow

Delisted

The Operating Cash Flow of Metsera (MTSR) as of Nov 3, 2026 is -99.79 M USD. In the previous year, Operating Cash Flow was -35.39 M USD — a change of 181.94% (lower).

Operating Cash Flow

-99.79 MUSD

YoY

181.94%

Last updated:

Operating Cash Flow of Metsera is 2024 -99.79 M USD. Operating Cash Flow of Metsera was 2023 -35.39 M USD. It decreases by 181.94% lower compared to the previous year.

The Metsera Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2022
-537,000.00 USD
Jan 1, 2023
-35.39 M USD
Jan 1, 2024
-99.79 M USD
The Metsera Operating Cash Flow history
YEAROperating Cash FlowYoY
-99.79 MUSD+181.94%
-35.39 MUSD+6,490.88%
-537,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Operating Cash Flow of Metsera is -99.79 M USD in 2024.

Operating Cash Flow of Metsera changed from -35.39 M USD to -99.79 M USD, representing a 181.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Metsera since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Metsera historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Metsera

All Key Metrics — Metsera